A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling "exciting" promise in late-stage trials.
A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling "exciting" promise in late-stage trials.
The Covid-19 vaccines have been recently revised by the World Health Organization where healthy children are given less priority to get a shot since they are at a lower risk
Covid-19 shots are included in new schedules of routinely recommended vaccines released by the US Centers for Disease Control and Prevention on Thursday. The immunization schedules summarize current vaccine recommendations